Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments
The Application of Clinical Genetics · 2014-04 · 55
DOI: 10.2147/tacg.s58444 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Application of Clinical Genetics, 2014-04. Verfasst von David Buchbinder und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Children's Hospital of Orange County, Orange, CA, USA. Die Arbeit wurde bisher 133-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology, Children's Hospital of Orange County, Orange, CA, USA.
- Division of Immunology, Cincinnati Children's Hospital, Cincinnati, OH, USA.
Zitieren
APA
Buchbinder, D., Nugent, D. J., & Fillipovich, A. H. (2014). Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments. The Application of Clinical Genetics, 55. https://doi.org/10.2147/tacg.s58444
Vancouver
Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments. The Application of Clinical Genetics. 2014:55. doi:10.2147/tacg.s58444
BibTeX
@article{Buchbinder2014,
author = {Buchbinder, David and Nugent, Diane J and Fillipovich, Alexandra H},
title = {Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments},
journal = {The Application of Clinical Genetics},
year = {2014},
pages = {55},
doi = {10.2147/tacg.s58444}
}
EUVIMED